We employed a comprehensive non-targeted metabolomics analysis of urine samples of 2- and 6-month-old of APP/PS1 mice after Xn treatment was performed to find differential metabolites and the biological pathways associated with AD. The gene discussed is APP; the disease is Alzheimer disease.